164 related articles for article (PubMed ID: 35068223)
21. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic-type acinar cell carcinoma of the stomach beneath a focus of pancreatic metaplasia of the gastric mucosa.
Ambrosini-Spaltro A; Potì O; De Palma M; Filotico M
Hum Pathol; 2009 May; 40(5):746-9. PubMed ID: 19144387
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic-type Mixed Acinar-neuroendocrine Carcinoma of the Stomach: A Case Report and Literature Review.
Saller J; Hough B; Coppola D
Cancer Diagn Progn; 2021; 1(4):285-288. PubMed ID: 35403148
[TBL] [Abstract][Full Text] [Related]
24. Acinar neoplasms of the pancreas-A summary of 25 years of research.
Klimstra DS; Adsay V
Semin Diagn Pathol; 2016 Sep; 33(5):307-18. PubMed ID: 27320062
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic Mixed Acinar-neuroendocrine-ductal Carcinoma: A Case Report and Literature Review.
Sakaguchi R; Yamada R; Nose K; Tanaka T; Murashima Y; Tsuboi J; Nakagawa H
Intern Med; 2023 Nov; 62(22):3347-3353. PubMed ID: 37032087
[TBL] [Abstract][Full Text] [Related]
26. Acinar cell carcinoma with hypervascularity.
Chen JD; Wu MS; Tien YW; Kuo KT; Chang MC; Lin JT
J Gastroenterol Hepatol; 2001 Jan; 16(1):107-11. PubMed ID: 11206307
[TBL] [Abstract][Full Text] [Related]
27. Pathology and genetics of pancreatic neoplasms with acinar differentiation.
Wood LD; Klimstra DS
Semin Diagn Pathol; 2014 Nov; 31(6):491-497. PubMed ID: 25441307
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.
Kusafuka K; Bando E; Muramatsu K; Ito H; Tanizawa Y; Kawamura T; Mochizuki T; Terashima M; Nakajima T
Med Mol Morphol; 2009 Sep; 42(3):167-74. PubMed ID: 19784744
[TBL] [Abstract][Full Text] [Related]
29. Mixed acinar-neuroendocrine-ductal carcinoma of the pancreas: a tale of three lineages.
Anderson MJ; Kwong CA; Atieh M; Pappas SG
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27257019
[TBL] [Abstract][Full Text] [Related]
30. Colonic carcinoma with a pancreatic acinar cell differentiation. A case report.
Chiaravalli AM; Finzi G; Bertolini V; La Rosa S; Capella C
Virchows Arch; 2009 Dec; 455(6):527-31. PubMed ID: 19908063
[TBL] [Abstract][Full Text] [Related]
31. Fine needle aspiration cytology of acinar cell carcinoma of the pancreas: a report of two cases.
Samuel LH; Frierson HF
Acta Cytol; 1996; 40(3):585-91. PubMed ID: 8669201
[TBL] [Abstract][Full Text] [Related]
32. Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
[TBL] [Abstract][Full Text] [Related]
33. Cytomorphologic and immunophenotypical features of acinar cell neoplasms of the pancreas.
Sigel CS; Klimstra DS
Cancer Cytopathol; 2013 Aug; 121(8):459-70. PubMed ID: 23408736
[TBL] [Abstract][Full Text] [Related]
34. Acinar cell carcinoma of the pancreas. Report of three cases.
Kuopio T; Ekfors TO; Nikkanen V; Nevalainen TJ
APMIS; 1995 Jan; 103(1):69-78. PubMed ID: 7695893
[TBL] [Abstract][Full Text] [Related]
35. Pancreatoblastoma in an adult: its separation from acinar cell carcinoma.
Hoorens A; Gebhard F; Kraft K; Lemoine NR; Klöppel G
Virchows Arch; 1994; 424(5):485-90. PubMed ID: 8032529
[TBL] [Abstract][Full Text] [Related]
36. Mixed acinar-neuroendocrine carcinoma of the pancreas: a case report and a review.
Jakobsen M; Klöppel G; Detlefsen S
Histol Histopathol; 2016 Dec; 31(12):1381-8. PubMed ID: 27081013
[TBL] [Abstract][Full Text] [Related]
37. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.
Kim JY; Brosnan-Cashman JA; Kim J; An S; Lee KB; Kim H; Park DY; Jang KT; Oh YH; Hruban RH; Heaphy CM; Hong SM
Pathology; 2020 Apr; 52(3):336-347. PubMed ID: 32111396
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
40. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
